(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (FY)Dec 31, 2021 | (Q9)Sep 30, 2021 | (FY)Dec 31, 2020 | |
---|---|---|---|---|---|---|---|
Turnover | --277.84M | 22.49%559.05M | 5.38%456.41M | 5.68%332.57M | 5.61%433.11M | --314.7M | --410.09M |
Operating income | 277.84M | 22.49%559.05M | 5.38%456.41M | 5.68%332.57M | 5.61%433.11M | 314.7M | 410.09M |
Cost of sales | ---163.07M | -37.46%-299.32M | 2.97%-217.74M | -0.03%-159.8M | -14.45%-224.42M | ---159.76M | ---196.08M |
Operating expenses | -163.07M | -37.46%-299.32M | 2.97%-217.74M | -0.03%-159.8M | -14.45%-224.42M | -159.76M | -196.08M |
Gross profit | 114.77M | 8.82%259.73M | 14.36%238.67M | 11.50%172.77M | -2.48%208.69M | 154.95M | 214.01M |
Selling expenses | ---68.8M | -15.00%-153.66M | -34.59%-133.61M | -31.31%-98.82M | 18.44%-99.27M | ---75.26M | ---121.71M |
Administrative expenses | ---23.08M | -29.29%-25.57M | -6.07%-19.77M | 0.19%-13.84M | 14.00%-18.64M | ---13.86M | ---21.68M |
Research and development expenses | ---17.58M | 2.90%-37.62M | 23.97%-38.74M | 26.01%-28.71M | 5.73%-50.95M | ---38.8M | ---54.05M |
Revaluation surplus | --97K | -85.26%-10.93M | ---5.9M | ---- | ---- | ---- | ---- |
-Changes in the fair value of financial assets | --97K | -85.26%-10.93M | ---5.9M | ---- | ---- | ---- | ---- |
Special items of operating profit | --1.68M | -58.81%2.57M | -43.14%6.23M | -111.04%-1M | -16.87%10.95M | --9.08M | --13.17M |
Operating profit | 7.08M | -26.34%34.53M | -7.69%46.88M | -15.81%30.4M | 70.71%50.78M | 36.11M | 29.75M |
Financing cost | ---1.87M | -296.15%-8.44M | -598.69%-2.13M | -303.00%-1.21M | 61.83%-305K | ---300K | ---799K |
Earning before tax | 5.22M | -41.70%26.09M | -11.35%44.75M | -18.48%29.19M | 74.36%50.48M | 35.81M | 28.95M |
Tax | ---1.82M | -261.62%-1.07M | 35.99%-297K | 371.57%812K | -119.69%-464K | ---299K | --2.36M |
After-tax profit from continuing operations | 3.4M | -43.73%25.01M | -11.12%44.45M | -15.51%30M | 59.75%50.01M | 35.51M | 31.31M |
Earning after tax | 3.4M | -43.73%25.01M | -11.12%44.45M | -15.51%30M | 59.75%50.01M | 35.51M | 31.31M |
Minority profit | --14K | ---- | ---- | 6.25%51K | ---- | --48K | ---- |
Profit attributable to shareholders | 3.39M | -43.73%25.01M | -11.12%44.45M | -15.54%29.95M | 59.75%50.01M | 35.46M | 31.31M |
Basic earnings per share | 0.0107 | ||||||
Diluted earnings per share | 0.0107 | ||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Ernst & Young | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data